Possible association between Budd-Chiari Syndrome and gemtuzumab ozogamicin treatment in a patient with refractory acute myelogenous leukemia

American Journal of Hematology

Volumn 80, Issue 3, 2005, Pages 213-215

  Kurt, Mevlüt ^a   Shorbagi, Ali ^a   Altundag, Kadri ^a,b   Elkiran, Tamer ^a   Güllü, Ibrahim ^a   Kansu, Emin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Hacettepe University Institute of Oncology ^*  (United States)

Author keywords

Acute myelogenous leukemia; Budd Chiari syndrome; Gemtuzumab ozogamicin; Refractory

Indexed keywords

AMIKACIN; CD33 ANTIGEN; CEFEPIME; CYTARABINE; GEMTUZUMAB OZOGAMICIN; IDARUBICIN; METRONIDAZOLE;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; BUDD CHIARI SYNDROME; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; HEPATIC VEIN; HUMAN; PRIORITY JOURNAL; VEIN OCCLUSION; VEIN THROMBOSIS;

AGED; AMINOGLYCOSIDES; ANTIBODIES, MONOCLONAL; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; SALVAGE THERAPY;

EID: 27644532080     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.20432     Document Type: Article

References (11)

1. Bross PF, Beitz J, Chen G, et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res 2001;7:1490-1496.
2. Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med 2004;350:578-585.
3. Majhail NS, Lichtin AE. Acute leukemia with a very high leukocyte count: confronting a medical emergency. Cleve Clin J Med 2004;71:633-637.
4. Riccio JA, Colley AT, Cera PJ. Hepatic vein thrombosis (Budd-Chiari syndrome) in the microgranular variant of acute promyelocytic leukemia. Am J Clin Pathol 1989;92:366-371.
5. Chillar RK, Paladugu RR. Case report: hepatic vein thrombosis (acute Budd-Chiari syndrome) in acute leukemia. Am J Med Sci 1981;282:153-156.
6. Teefey SA, Brink JA, Borson RA, Middleton WD. Diagnosis of veno-occlusive disease of the liver after bone marrow transplantation: value of duplex sonography AJR Am J Roentgenol 1995; 164:1397-1401.
7. Millener P, Grant EG, Rose S, et al. Color Doppler imaging findings in patients with Budd-Chiari syndrome: correlation with venographic findings. AJR Am J Roentgenol 1993;161:307-312.
8. Giles FJ, Kantarjian HM, Kornblau SM, et al. GO (gemtuzumab ozogamicin) therapy is associated with hepatic veno-occlusive disease in patients who have not received stem cell transplantation. Cancer 2001;92:406-413.
9. Favaloro EJ. Differential expression of surface antigens on activated endothelium. Immunol Cell Biol 1993;71(Pt 6):571-581.
10. Vallaeys JH, Praet MM, Roels HJ, Van Marck E, Kaufman L. The Budd-Chiari syndrome caused by a zygomycete. A new pathogenesis of hepatic vein thrombosis. Arch Pathol Lab Med 1989; 113:1171-1174.
11. Young RC. The Budd-Chiari syndrome caused by Aspergillus; two patients with vascular invasion of the hepatic veins. Arch Intern Med 1969;124:754-757.